12309 |
OOC-230201KAM-1 |
OOC-230201KAM-1 |
Fibrin Clots Control 0% |
CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6 |
Clot Formation |
0% Plasma |
Emmanuel Angelidakis |
P.KAM-230131-V1_clot-generate-and-image-analysis.docx |
P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx |
Polydimethylsiloxane |
12310 |
OOC-230201KAM-2 |
OOC-230201KAM-2 |
Fibrin Clots 5% |
CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6 |
Clot Formation |
5% Plasma |
Emmanuel Angelidakis |
P.KAM-230131-V1_clot-generate-and-image-analysis.docx |
P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx |
Polydimethylsiloxane |
12311 |
OOC-230201KAM-3 |
OOC-230201KAM-3 |
Fibrin Clots 25% |
CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6 |
Clot Formation |
25% Plasma |
Emmanuel Angelidakis |
P.KAM-230131-V1_clot-generate-and-image-analysis.docx |
P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx |
Polydimethylsiloxane |
12312 |
OOC-230201KAM-4 |
OOC-230201KAM-4 |
Fibrin Clots 50% |
CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6 |
Clot Formation |
50% Plasma |
Emmanuel Angelidakis |
P.KAM-230131-V1_clot-generate-and-image-analysis.docx |
P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx |
Polydimethylsiloxane |
12313 |
OOC-230201KAM-5 |
OOC-230201KAM-5 |
Beads Control |
CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6 |
Bead Perfusion |
0% Plasma |
Emmanuel Angelidakis |
P.KAM-230131-V1_clot-generate-and-image-analysis.docx |
P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx |
Polydimethylsiloxane |
12314 |
OOC-230201KAM-6 |
OOC-230201KAM-6 |
Beads 5% |
CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6 |
Bead Perfusion |
5% Plasma |
Emmanuel Angelidakis |
P.KAM-230131-V1_clot-generate-and-image-analysis.docx |
P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx |
Polydimethylsiloxane |
12315 |
OOC-230201KAM-7 |
OOC-230201KAM-7 |
Beads 25% |
CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6 |
Bead Perfusion |
25% Plasma |
Emmanuel Angelidakis |
P.KAM-230131-V1_clot-generate-and-image-analysis.docx |
P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx |
Polydimethylsiloxane |
12316 |
OOC-230201KAM-8 |
OOC-230201KAM-8 |
Beads 50% |
CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6 |
Bead Perfusion |
50% Plasma |
Emmanuel Angelidakis |
P.KAM-230131-V1_clot-generate-and-image-analysis.docx |
P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx |
Polydimethylsiloxane |
12317 |
OOC-230201KAM-10 |
OOC-230201KAM-10 |
Fibrin Clots 25% and Dextran |
CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6 |
Clot Formation |
25% Plasma; Dextran |
Emmanuel Angelidakis |
P.KAM-230131-V1_clot-generate-and-image-analysis.docx |
P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx |
Polydimethylsiloxane |
12318 |
OOC-230201KAM-11 |
OOC-230201KAM-11 |
MDA-MB-231 Extravasation Control |
CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-3 |
Cancer Cell Extravasation |
Control |
Emmanuel Angelidakis |
P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx |
P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx |
Polydimethylsiloxane |
12319 |
OOC-230201KAM-12 |
OOC-230201KAM-12 |
MDA-MB-231 Extravasation Fibrinogen |
CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-3 |
Cancer Cell Extravasation |
Fibrinogen |
Emmanuel Angelidakis |
P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx |
P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx |
Polydimethylsiloxane |
12320 |
OOC-230201KAM-13 |
OOC-230201KAM-13 |
MDA-MB-231 Extravasation Thrombin |
CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-3 |
Cancer Cell Extravasation |
Thrombin |
Emmanuel Angelidakis |
P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx |
P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx |
Polydimethylsiloxane |
12321 |
OOC-230201KAM-14 |
OOC-230201KAM-14 |
MDA-MB-231 Extravasation Fibrinogen and anti-ICAM1 antibody |
CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-3 |
Cancer Cell Extravasation |
Fibrinogen; anti-ICAM1 antibody |
Emmanuel Angelidakis |
P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx |
P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx |
Polydimethylsiloxane |
12322 |
OOC-230201KAM-15 |
OOC-230201KAM-15 |
MDA-MB-231 Extravasation Thrombin and anti-PAR1 |
CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-3 |
Cancer Cell Extravasation |
Thrombin; PM2 |
Emmanuel Angelidakis |
P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx |
P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx |
Polydimethylsiloxane |
12323 |
OOC-230201KAM-16 |
OOC-230201KAM-16 |
SKBR3 Extravasation Control |
CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-4 |
Cancer Cell Extravasation |
Control |
Emmanuel Angelidakis |
P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx |
P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx |
Polydimethylsiloxane |
12324 |
OOC-230201KAM-17 |
OOC-230201KAM-17 |
SKBR3 Extravasation Fibrinogen |
CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-4 |
Cancer Cell Extravasation |
Fibrinogen |
Emmanuel Angelidakis |
P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx |
P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx |
Polydimethylsiloxane |
12325 |
OOC-230201KAM-18 |
OOC-230201KAM-18 |
MCF7 Extravasation Control |
CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-5 |
Cancer Cell Extravasation |
Control |
Emmanuel Angelidakis |
P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx |
P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx |
Polydimethylsiloxane |
12326 |
OOC-230201KAM-19 |
OOC-230201KAM-19 |
MCF7 Extravasation Thrombin |
CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-5 |
Cancer Cell Extravasation |
Thrombin |
Emmanuel Angelidakis |
P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx |
P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx |
Polydimethylsiloxane |
12327 |
OOC-230207KAM-1 |
OOC-230207KAM-1 |
MDA-MB-231 Extravasation Fibrin |
CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-3 |
Cancer Cell Extravasation |
10% Plasma |
Emmanuel Angelidakis |
P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx |
P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx |
Polydimethylsiloxane |
12328 |
OOC-230207KAM-2 |
OOC-230207KAM-2 |
Permeability Baseline |
CEL-230131KAM-1; CEL-230131KAM-2 |
Permeability |
Control |
Emmanuel Angelidakis |
P.KAM-230131-V1_Confocal-imaging.docx |
P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx |
Polydimethylsiloxane |
12329 |
OOC-230207KAM-3 |
OOC-230207KAM-3 |
Permeability Thrombin |
CEL-230131KAM-1; CEL-230131KAM-2 |
Permeability |
Thrombin |
Emmanuel Angelidakis |
P.KAM-230131-V1_Confocal-imaging.docx |
P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx |
Polydimethylsiloxane |
12330 |
OOC-230207KAM-5 |
OOC-230207KAM-5 |
Permeability 25% Plasma |
CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6 |
Permeability |
25% Plasma |
Emmanuel Angelidakis |
P.KAM-230131-V1_Confocal-imaging.docx |
P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx |
Polydimethylsiloxane |
12331 |
OOC-230217KAM-1 |
OOC-230217KAM-1 |
Permeability Cold Control |
CEL-230131KAM-1; CEL-230131KAM-2 |
Permeability |
Cold Control |
Emmanuel Angelidakis |
P.KAM-230131-V1_Confocal-imaging.docx |
P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx |
Polydimethylsiloxane |
12332 |
OOC-230217KAM-2 |
OOC-230217KAM-2 |
MDA-MB-231 Extravasation Fibrinogen and siRNA scramble control |
CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-3 |
Cancer Cell Extravasation |
Fibrinogen; scramble siRNA negative control |
Sarah Shelton |
P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx |
P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx |
Polydimethylsiloxane |
12333 |
OOC-230217KAM-3 |
OOC-230217KAM-3 |
MDA-MB-231 Extravasation Fibrinogen and anti-ICAM1 siRNA1 |
CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-3 |
Cancer Cell Extravasation |
Fibrinogen; anti-ICAM1 siRNA1 |
Sarah Shelton |
P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx |
P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx |
Polydimethylsiloxane |
12334 |
OOC-230217KAM-4 |
OOC-230217KAM-4 |
MDA-MB-231 Extravasation Fibrinogen and anti-ICAM1 siRNA2 |
CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-3 |
Cancer Cell Extravasation |
Fibrinogen; anti-ICAM1 siRNA2 |
Sarah Shelton |
P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx |
P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx |
Polydimethylsiloxane |
12335 |
OOC-230217KAM-5 |
OOC-230217KAM-5 |
Platelet clots |
CEL-230131KAM-1; CEL-230131KAM-2; CEL-230217KAM-1 |
Clot Formation |
10% Plasma with platelets |
Emmanuel Angelidakis |
P.KAM-230131-V1_clot-generate-and-image-analysis.docx |
P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx |
Polydimethylsiloxane |
12336 |
OOC-230217KAM-6 |
OOC-230217KAM-6 |
MCF7 Extravasation Thrombin and anti-PAR1 |
CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-5 |
Cancer Cell Extravasation |
Thrombin; PM2 |
Emmanuel Angelidakis |
P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx |
P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx |
Polydimethylsiloxane |
12337 |
OOC-230217KAM-7 |
OOC-230217KAM-7 |
SKBR3 Extravasation Fibrinogen and anti-ICAM1 |
CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-4 |
Cancer Cell Extravasation |
Fibrinogen; anti-ICAM1 antibody |
Emmanuel Angelidakis |
P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx |
P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx |
Polydimethylsiloxane |